Gastroenterology
Volume 133, Issue 2 , Pages 713-716 , August 2007

Seek and Hide Phosphatidylserine: A New Approach to Prevent Hepatic Ischemia/Reperfusion Injury

  • Emanuele Albano

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: Emanuele Albano, MD, Department of Medical Sciences, University “Amedeo Avogadro” of East Piedmont, via Solaroli 17, 28100 Novara, Italy.

References 

  1. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg. 2001;181:160–166
  2. Selzner M, Clavien P-A. Fatty liver in liver transplantation and surgery. Semin Liver Dis. 2001;21:105–113
  3. Broelsch C, Testa G, Alexandrou A, et al. Living related liver transplantation: medial and social aspect of a controversial therapy. Gut. 2002;5:143–145
  4. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology. 2003;125:1246–1257
  5. Carini R, Autelli R, Bellomo G, et al. Alterations of cell volume regulation in the development of hepatocyte necrosis. Exp Cell Res. 1999;248:280–293
  6. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology. 2006;43:S31–S44
  7. Jaeschke H. Mechanisms of liver injury II (Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions). Am J Physiol. 2006;290:G1083–G1088
  8. Bilzer M, Gerbes A. Preservation injury of the liver (Mechanisms and novel therapeutic strategies). J Hepatol. 2000;32:508–515
  9. Selzner N, Rudiger H, Graf R, et al. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917–936
  10. Casillas-Ramirez A, Mosbah IB, Ramalho F, et al. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci. 2006;79:1881–1894
  11. Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology. 2003;125:1480–1491
  12. Carini R, Alchera E, De Cesaris MG, et al. Purinergic P2Y2 receptors promote hepatocyte resistance to hypoxia. J Hepatol. 2006;45:236–245
  13. Iniguez M, Berasain C, Martinez-Anso E, et al. Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning. J Exp Med. 2006;203:2809–2815
  14. Banga NR, Homer-Vanniasinkam , Graham A, et al. Ischemic preconditioning in transplantation and major resection of the liver. Br J Surg. 2005;92:528–538
  15. Serafin A, Roselo-Catafau J, Prats N, et al. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol. 2002;161:587–601
  16. Gou RF, Roselo-Catafau J, Casillas-Ramirez A, et al. How ischemic preconditioning protects small liver grafts. J Pathol. 2006;208:62–73
  17. Glantzounis GK, Salacinski HJ, Yang W, et al. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl. 2005;11:1031–1047
  18. Glantazounis GK, Mikhailidis DP, Seifalian AM, Davidson BR (eds). Curr Pharm Des 2007;12:2867–2992.
  19. Teoh NC, Ito Y, Field J, et al. Diannexin, a novel Annexin V homodimer, provides prolonged protection against hepatic ischemia reperfusion injury in mice. Gastroenterology. 2007;133:632–646
  20. Kuypers FA, Larkin SK, Emeis JJ, et al. Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity. Thromb Haemost. 2007;97:478–486
  21. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev. 2002;82:331–371
  22. Boersma HH, Kietselaer BL, Stolk LM, et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med. 2005;46:2035–2050
  23. Reutelingsperger CP. Annexins: key regulators of haemostasis, thrombosis, and apoptosis. Thromb Haemost. 2001;86:413–419
  24. Hammill AK, Uhr JW, Scheuermann RH. Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic cell death. Exp Cell Res. 1999;251:16–21
  25. Natori S, Selzner M, Valentino KL, et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation. 1999;68:89–96
  26. Gujral J, Bucci T, Farhood A, et al. Mechanisms of cell death during warm hepatic ischemia-reperfusion in rat: apoptosis or necrosis. Hepatology. 2001;33:397–405
  27. Qin X, Gao B. The complement system in liver diseases. Cell Mol Immunol. 2006;3:333–340
  28. Arumugam TV, Shiels IA, Woodruff TM, et al. The role of the complement system in ischemia-reperfusion injury. Shock. 2004;21:401–409
  29. Mold C, Morris CA. Complement activation by apoptotic endothelial cells following hypoxia/reoxygenation. Immunol. 2001;102:359–364
  30. Freyssinet JM. Cellular microparticles: what are they bad or good for?. J Throm Heamost. 2003;1:1655–1662
  31. Morel O, Toti F, Hugel B, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation?. Artheroscler Thromb Vasc Biol. 2006;26:2594–2604

PII: S0016-5085(07)01171-7

doi: 10.1053/j.gastro.2007.06.030

Gastroenterology
Volume 133, Issue 2 , Pages 713-716 , August 2007

Article Tools

* Image Usage & Resolution